Overview

A First Time in Human Study of PIN201104 in Healthy Volunteers and Patients With Asthma

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of different single and repeat doses of PIN201104 in healthy volunteers and in patients with asthma.
Phase:
Phase 1
Details
Lead Sponsor:
Peptinnovate